Insulet (PODD) Tax Rate Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,062.00 |
| Dec 31, 2025 | 1,989.00 |
| Sep 30, 2025 | 1,523.00 |
| Jun 30, 2025 | 353.00 |
| Mar 31, 2025 | 712.00 |
| Dec 31, 2024 | -1,687.00 |
| Sep 30, 2024 | -2,076.00 |
| Jun 30, 2024 | -29,540.00 |
| Mar 31, 2024 | -19.00 |
| Dec 31, 2023 | -468.00 |
| Sep 30, 2023 | -712.00 |
| Jun 30, 2023 | 3,642.00 |
| Mar 31, 2023 | 806.00 |
| Dec 31, 2022 | 2,207.00 |
| Sep 30, 2022 | 1,452.00 |
| Jun 30, 2022 | 436.00 |
| Mar 31, 2022 | 613.00 |
| Dec 31, 2021 | 1,472.00 |
| Sep 30, 2021 | 2,049.00 |
| Jun 30, 2021 | 1,349.00 |
| Mar 31, 2021 | 10,094.00 |
| Dec 31, 2020 | 839.00 |
| Sep 30, 2020 | 1,368.00 |
| Jun 30, 2020 | 1,733.00 |
| Mar 31, 2020 | 1,946.00 |
| Dec 31, 2019 | 2,240.00 |
| Sep 30, 2019 | 2,747.00 |
| Jun 30, 2019 | 2,649.00 |
| Mar 31, 2019 | 745.00 |
| Dec 31, 2018 | 304.00 |
| Sep 30, 2018 | 1,049.00 |
| Jun 30, 2018 | -3,108.00 |
| Mar 31, 2018 | -357.00 |
| Dec 31, 2017 | 238.00 |
| Sep 30, 2017 | -552.00 |
| Jun 30, 2017 | -84.00 |
| Mar 31, 2017 | -70.00 |
| Dec 31, 2016 | -125.00 |
| Jun 30, 2016 | -5,990.00 |